Rivercell raises $25m to build an AI model of how human cells respond to treatment
Rivercell has launched with a $25 million seed round to build an AI model of how human cells respond to drugs and genetic changes. The Paris-based company’s plan pairs its own biological data engine with an automated wet lab, tackling a dat
Open discussion →